TW202417843A - 游離血紅素測定試劑、游離血紅素的測定方法及抗血紅素抗體 - Google Patents
游離血紅素測定試劑、游離血紅素的測定方法及抗血紅素抗體 Download PDFInfo
- Publication number
- TW202417843A TW202417843A TW112133741A TW112133741A TW202417843A TW 202417843 A TW202417843 A TW 202417843A TW 112133741 A TW112133741 A TW 112133741A TW 112133741 A TW112133741 A TW 112133741A TW 202417843 A TW202417843 A TW 202417843A
- Authority
- TW
- Taiwan
- Prior art keywords
- hemoglobin
- free
- heme
- antibody
- chain
- Prior art date
Links
- 108010054147 Hemoglobins Proteins 0.000 title claims abstract description 179
- 102000001554 Hemoglobins Human genes 0.000 title claims abstract description 179
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 123
- 238000005259 measurement Methods 0.000 title abstract description 29
- 238000000691 measurement method Methods 0.000 title abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 87
- 230000009257 reactivity Effects 0.000 claims abstract description 83
- 238000006243 chemical reaction Methods 0.000 claims abstract description 62
- 102000006395 Globulins Human genes 0.000 claims description 110
- 108010044091 Globulins Proteins 0.000 claims description 110
- 238000003556 assay Methods 0.000 claims description 63
- 239000002245 particle Substances 0.000 claims description 35
- 102100027685 Hemoglobin subunit alpha Human genes 0.000 claims description 16
- 108091005902 Hemoglobin subunit alpha Proteins 0.000 claims description 16
- 108010036302 hemoglobin AS Proteins 0.000 claims description 16
- 102100021519 Hemoglobin subunit beta Human genes 0.000 claims description 14
- 108091005904 Hemoglobin subunit beta Proteins 0.000 claims description 14
- 108010071602 haptoglobin-hemoglobin complex Proteins 0.000 abstract 1
- 150000003278 haem Chemical class 0.000 description 94
- 239000004816 latex Substances 0.000 description 26
- 229920000126 latex Polymers 0.000 description 26
- 230000001186 cumulative effect Effects 0.000 description 23
- 230000002776 aggregation Effects 0.000 description 15
- 238000004220 aggregation Methods 0.000 description 15
- 239000004793 Polystyrene Substances 0.000 description 11
- 238000001962 electrophoresis Methods 0.000 description 11
- 229920002223 polystyrene Polymers 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 230000001900 immune effect Effects 0.000 description 8
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000004520 agglutination Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000000539 dimer Substances 0.000 description 5
- 239000011259 mixed solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 239000007995 HEPES buffer Substances 0.000 description 4
- 230000007910 cell fusion Effects 0.000 description 4
- 238000007398 colorimetric assay Methods 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 201000006491 bone marrow cancer Diseases 0.000 description 2
- -1 carboxylic acid imide Chemical class 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000003317 immunochromatography Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 210000004926 tubular epithelial cell Anatomy 0.000 description 2
- 241000283707 Capra Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 241000609499 Palicourea Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000473945 Theria <moth genus> Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 102000014452 scavenger receptors Human genes 0.000 description 1
- 108010078070 scavenger receptors Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022140537 | 2022-09-05 | ||
| JP2022-140537 | 2022-09-05 | ||
| WOPCT/JP2023/032151 | 2023-09-01 | ||
| PCT/JP2023/032151 WO2024053586A1 (ja) | 2022-09-05 | 2023-09-01 | 遊離ヘモグロビン測定試薬、遊離ヘモグロビン測定方法および抗ヘモグロビン抗体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202417843A true TW202417843A (zh) | 2024-05-01 |
Family
ID=90191126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW112133741A TW202417843A (zh) | 2022-09-05 | 2023-09-05 | 游離血紅素測定試劑、游離血紅素的測定方法及抗血紅素抗體 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP7543575B2 (https=) |
| TW (1) | TW202417843A (https=) |
| WO (1) | WO2024053586A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU529210B3 (en) * | 1983-02-02 | 1983-04-14 | Australian Monoclonal Development Pty. Ltd. | Monoclonal antibody in occult blood diagnosis |
| JPH0324458A (ja) * | 1989-06-21 | 1991-02-01 | Daiso Co Ltd | 尿中赤血球の免疫学的測定法 |
| JPH05209879A (ja) * | 1992-01-31 | 1993-08-20 | Godo Shiyusei Kk | ヘモグロビンの免疫学的検出方法 |
| JPH10132824A (ja) * | 1996-10-28 | 1998-05-22 | Eiken Chem Co Ltd | ヘモグロビンの安定化方法 |
| JPH11201969A (ja) * | 1998-01-14 | 1999-07-30 | Wakamoto Pharmaceut Co Ltd | 簡易遊離ヘモグロビン測定方法および測定用キット |
| EA022609B1 (ru) * | 2007-02-12 | 2016-02-29 | А1М Фарма Аб | Применение свободного фетального гемоглобина в качестве маркера преэклампсии |
| WO2015191450A1 (en) * | 2014-06-13 | 2015-12-17 | Siemens Healthcare Diagnostics Inc. | Detection of hemolysis using a chromatographic detection pad |
-
2023
- 2023-09-01 JP JP2023571225A patent/JP7543575B2/ja active Active
- 2023-09-01 WO PCT/JP2023/032151 patent/WO2024053586A1/ja not_active Ceased
- 2023-09-05 TW TW112133741A patent/TW202417843A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024053586A1 (ja) | 2024-03-14 |
| JPWO2024053586A1 (https=) | 2024-03-14 |
| JP7543575B2 (ja) | 2024-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7508494B2 (ja) | ヘモグロビンの測定試薬、測定キット及び測定方法 | |
| JP7253306B2 (ja) | 免疫比濁法によるカルシウム結合タンパク質ｓ１００ファミリーメンバーの測定方法 | |
| CN101896820A (zh) | 区分测定 | |
| JPWO2020067396A1 (ja) | 糖化ヘモグロビン（％）の測定方法 | |
| TWI800483B (zh) | 抗人類血紅素單株抗體或抗體套組、抗人類血紅素單株抗體固定化不可溶性載體粒子、及使用其等之測定試劑或測定方法 | |
| TW202417843A (zh) | 游離血紅素測定試劑、游離血紅素的測定方法及抗血紅素抗體 | |
| TW202429079A (zh) | 游離血紅素的測定方法及游離血紅素的測定試劑 | |
| JP2023100882A (ja) | ヘモグロビンとハプトグロビンとの複合体を安定化する方法、及びヘモグロビンを含む検体を保存するための保存溶液 | |
| JP4488460B2 (ja) | 免疫分析方法および試薬 | |
| JP2649016B2 (ja) | 免疫反応干渉作用の除去方法 | |
| EP4350355A2 (en) | Improved assay | |
| EP4675276A1 (en) | Method for immunologically measuring hemoglobin using deglycosylated haptoglobin | |
| JP2678273B2 (ja) | 免疫定量法 | |
| JPH09281104A (ja) | 偽陰性反応防止方法 | |
| WO2024004805A1 (ja) | 免疫学的測定方法 | |
| HK40049478B (en) | Hemoglobin assay reagent, assay kit and assay method | |
| HK40049478A (en) | Hemoglobin assay reagent, assay kit and assay method | |
| JP2004012170A (ja) | 免疫学的測定法および測定用キット | |
| CN109716132A (zh) | 免疫学测定方法和测定试剂 | |
| HK40025683B (zh) | 使血红蛋白与触珠蛋白的复合物稳定的方法和用於保存含有血红蛋白的样本的保存溶液 | |
| JP2008058007A (ja) | 結合親和性を利用する被検物質の測定方法、及び被検物質の測定のための結合親和性解析の制御方法 | |
| HK1189937B (en) | Distinguishing assay |